Cargando…
Association of Antihypertensive Effects of Esaxerenone with the Internal Sodium Balance in Dahl Salt-Sensitive Hypertensive Rats
Background: The nonsteroidal mineralocorticoid receptor blocker esaxerenone is effective in reducing blood pressure (BP). Objective: In this study, we investigated esaxerenone-driven sodium homeostasis and its association with changes in BP in Dahl salt-sensitive (DSS) hypertensive rats. Methods: In...
Autores principales: | Hattori, Mai, Rahman, Asadur, Kidoguchi, Satoshi, Jahan, Nourin, Fujisawa, Yoshihide, Morisawa, Norihiko, Ohsaki, Hiroyuki, Kobara, Hideki, Masaki, Tsutomu, Hossain, Akram, Steeve, Akumwami, Nishiyama, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408866/ https://www.ncbi.nlm.nih.gov/pubmed/36012182 http://dx.doi.org/10.3390/ijms23168915 |
Ejemplares similares
-
Cardioprotective Effects of a Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, in Dahl Salt-Sensitive Hypertensive Rats
por: Rahman, Asadur, et al.
Publicado: (2021) -
Association of a Disrupted Dipping Pattern of Blood Pressure with Progression of Renal Injury during the Development of Salt-Dependent Hypertension in Rats
por: Sufiun, Abu, et al.
Publicado: (2020) -
Oxidative Stress-Induced Glomerular Mineralocorticoid Receptor Activation Limits the Benefit of Salt Reduction in Dahl Salt-Sensitive Rats
por: Kitada, Kento, et al.
Publicado: (2012) -
Antihypertensive Effects of Esaxerenone in Older Patients with Primary Aldosteronism
por: Fujimoto, Masanori, et al.
Publicado: (2023) -
Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction
por: Ito, Sadayoshi, et al.
Publicado: (2020)